Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recentl...

Full description

Bibliographic Details
Main Authors: Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820948047
id doaj-fc65bc8ab4fb45f98bb53cb7d2fccc25
record_format Article
spelling doaj-fc65bc8ab4fb45f98bb53cb7d2fccc252020-11-25T02:50:30ZengSAGE PublishingCancer Control1073-27482020-08-012710.1177/1073274820948047Immunotherapy in Biliary Tract Cancer: Worthy of a Second LookAngela Dalia Ricci0Alessandro Rizzo1Giovanni Brandi2 Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyAlthough immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.https://doi.org/10.1177/1073274820948047
collection DOAJ
language English
format Article
sources DOAJ
author Angela Dalia Ricci
Alessandro Rizzo
Giovanni Brandi
spellingShingle Angela Dalia Ricci
Alessandro Rizzo
Giovanni Brandi
Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
Cancer Control
author_facet Angela Dalia Ricci
Alessandro Rizzo
Giovanni Brandi
author_sort Angela Dalia Ricci
title Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
title_short Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
title_full Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
title_fullStr Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
title_full_unstemmed Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
title_sort immunotherapy in biliary tract cancer: worthy of a second look
publisher SAGE Publishing
series Cancer Control
issn 1073-2748
publishDate 2020-08-01
description Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.
url https://doi.org/10.1177/1073274820948047
work_keys_str_mv AT angeladaliaricci immunotherapyinbiliarytractcancerworthyofasecondlook
AT alessandrorizzo immunotherapyinbiliarytractcancerworthyofasecondlook
AT giovannibrandi immunotherapyinbiliarytractcancerworthyofasecondlook
_version_ 1724738195292160000

Similar Items